What is the Prognosis for Myeloproliferative Disorders?
The prognosis of MPDs varies widely depending on the specific disorder and individual patient factors. Generally, patients with essential thrombocythemia have a relatively normal life expectancy, while those with polycythemia vera and myelofibrosis may have a shorter survival due to complications such as thrombosis, bleeding, or transformation to acute leukemia. Regular follow-up and monitoring are essential for managing these conditions and improving outcomes.
